Cargando…
SAT-568 Glutamine Metabolism Is a New Potential Therapeutic Target in Aggressive Thyroid Cancer
Thyroid cancer is the most frequent endocrine tumor. BRAF mutation is the most frequent alteration in thyroid cancer. The metabolic consequences of these mutations is unknown. Recent studies have suggested a pro-metastatic role of the metabolic processes in several solid malignancies. The aim of thi...
Autores principales: | Patel, Dhaval, King, Timothy, Kebebew, Electron, Nilubol, Naris, Boufraqech, Myriem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551700/ http://dx.doi.org/10.1210/js.2019-SAT-568 |
Ejemplares similares
-
SUN-349 Prognostic Metabolic Signature in Aggressive Adrenocortical Carcinoma
por: Tirosh, Amit, et al.
Publicado: (2019) -
SAT568 A Case Of Medullary Thyroid Cancer Associated With Cutaneous Metastasis: A Rare And Aggressive Presentation
por: Vaghasia, Nishit, et al.
Publicado: (2023) -
Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome
por: Boufraqech, Myriem, et al.
Publicado: (2019) -
New Therapies for Advanced Thyroid Cancer
por: Laha, Diprajan, et al.
Publicado: (2020) -
Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer
por: Zhang, Lisa, et al.
Publicado: (2016)